Maximilien Minon1, Clothilde Soriano2, David Morland3,4, Thomas Walter5, Côme Lepage6, Antoine Tabarin7, Mathilde Deblock8, Pascal Rousset9, Coralie Barbe10, Christine Hoeffel11,4, Guillaume Cadiot2. 1. Department of Radiology, Robert-Debré University Hospital, Reims, France. minon.maximilien@gmail.com. 2. Department of Hepato-Gastroenterology and Digestive Oncology, Robert-Debré University Hospital, Reims, France. 3. Department of Nuclear Medicine, Institut Jean-Godinot, Biophysics laboratory, UFR Medecine, Université de Reims Champagne-Ardenne (URCA), Reims, France. 4. CRESTIC, EA 3804, Université de Reims Champagne-Ardenne (URCA), Reims, France. 5. Department of Digestive Oncology, Edouard Herriot Hospital, Lyon, France. 6. Gastroenterology & Digestive Oncology, University Hospital Le Bocage, Dijon, France. 7. Department of Endocrinology, Diabetology and Nutrition, Haut-Lévêque Hospital, Pessac, France. 8. Department of Medical Oncology, Lorraine Cancer Institute, Vandoeuvre-les-Nancy, France. 9. Radiology Department, Lyon Sud University Hospital, Hospices Civils de Lyon, Lyon, France. 10. Clinical Research Coordination Unit, Robert-Debré University Hospital, Reims, France. 11. Department of Radiology, Robert-Debré University Hospital, Reims, France.
Abstract
AIM: To determine whether whole-body magnetic resonance imaging is valuable in staging of neuroendocrine tumors by comparison with the conventional imaging defined by the combination of computed tomography and somatostatin receptor scintigraphy. METHODS: This study concerned the patients included in the multicenter prospective study NCT02786303 with the following inclusion criteria: well-differentiated gastroenteropancreatic neuroendocrine tumors or of unknown primary, and computed tomography, whole-body magnetic resonance imaging and somatostatin receptor scintigraphy performed within 6 weeks. Results of the conventional imaging were compared with those of magnetic resonance imaging. Discrepancies between the conventional imaging and magnetic resonance imaging were evaluated by reviewing medical records. RESULTS: Thirty-one patients (17 men and 14 women) were prospectively included. Complete concordance between the magnetic resonance imaging and the conventional imaging results was observed in 25 patients and discrepancies in 6. Whole-body magnetic resonance imaging detected more liver lesions than the conventional imaging did but standard imaging set was more effective in the detection of bone and peritoneum lesions than magnetic resonance imaging. Detecting more lesions had no impact on therapeutic management. CONCLUSIONS: Whole-body magnetic resonance imaging including diffusion weighted may be a valuable alternative to computed tomography and somatostatin receptor scintigraphy. Further studies should compare whole-body MRI to the 68Ga PET/CT.
AIM: To determine whether whole-body magnetic resonance imaging is valuable in staging of neuroendocrine tumors by comparison with the conventional imaging defined by the combination of computed tomography and somatostatin receptor scintigraphy. METHODS: This study concerned the patients included in the multicenter prospective study NCT02786303 with the following inclusion criteria: well-differentiated gastroenteropancreatic neuroendocrine tumors or of unknown primary, and computed tomography, whole-body magnetic resonance imaging and somatostatin receptor scintigraphy performed within 6 weeks. Results of the conventional imaging were compared with those of magnetic resonance imaging. Discrepancies between the conventional imaging and magnetic resonance imaging were evaluated by reviewing medical records. RESULTS: Thirty-one patients (17 men and 14 women) were prospectively included. Complete concordance between the magnetic resonance imaging and the conventional imaging results was observed in 25 patients and discrepancies in 6. Whole-body magnetic resonance imaging detected more liver lesions than the conventional imaging did but standard imaging set was more effective in the detection of bone and peritoneum lesions than magnetic resonance imaging. Detecting more lesions had no impact on therapeutic management. CONCLUSIONS: Whole-body magnetic resonance imaging including diffusion weighted may be a valuable alternative to computed tomography and somatostatin receptor scintigraphy. Further studies should compare whole-body MRI to the 68Ga PET/CT.
Authors: Thomas A Hope; Emily K Bergsland; Murat Fani Bozkurt; Michael Graham; Anthony P Heaney; Ken Herrmann; James R Howe; Matthew H Kulke; Pamela L Kunz; Josh Mailman; Lawrence May; David C Metz; Corina Millo; Sue O'Dorisio; Diane L Reidy-Lagunes; Michael C Soulen; Jonathan R Strosberg Journal: J Nucl Med Date: 2017-10-12 Impact factor: 10.057
Authors: Clarisse Dromain; Thierry de Baere; Jean Lumbroso; Hubert Caillet; Agnès Laplanche; Valerie Boige; Michel Ducreux; Pierre Duvillard; Dominique Elias; Martin Schlumberger; Robert Sigal; Eric Baudin Journal: J Clin Oncol Date: 2005-01-01 Impact factor: 44.544
Authors: Thomas C Kwee; Henriette M E Quarles van Ufford; Frederik J Beek; Taro Takahara; Cuno S Uiterwaal; Marc B Bierings; Inge Ludwig; Rob Fijnheer; Rutger A J Nievelstein Journal: Invest Radiol Date: 2009-10 Impact factor: 6.016
Authors: Arvind Dasari; Chan Shen; Daniel Halperin; Bo Zhao; Shouhao Zhou; Ying Xu; Tina Shih; James C Yao Journal: JAMA Oncol Date: 2017-10-01 Impact factor: 31.777
Authors: G Rindi; G Klöppel; H Alhman; M Caplin; A Couvelard; W W de Herder; B Erikssson; A Falchetti; M Falconi; P Komminoth; M Körner; J M Lopes; A-M McNicol; O Nilsson; A Perren; A Scarpa; J-Y Scoazec; B Wiedenmann Journal: Virchows Arch Date: 2006-09-12 Impact factor: 4.064